News

Published on 5 Nov 2023 on Insider Monkey via Yahoo Finance

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Q3 2023 Earnings Call Transcript


Article preview image

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Q3 2023 Earnings Call Transcript November 4, 2023

Operator: Good morning, and thank you for standing by. Welcome to Atara Biotherapeutics’ Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please be advised that today’s call is being recorded. I would now like to hand the call over to Alex Chapman, Vice President of Corporate Communications and Investor Relations at Atara Biotherapeutics. Please go ahead, sir.

Alex Chapman: Thank you, Sherry. Good morning, everyone, and welcome to Atara’s conference call to discuss our expanded tab-cel global partnership with Pierre Fabre Laboratories and our third quarter 2023 update. Earlier today, we issued a press release announcing this partnership and our third quarter financial results. This press release and an updated slide deck are available in the Investors & Media section at atarabio.com. Joining me on today’s call are Dr. Pascal Touchon, President and Chief Executive Officer; and Eric Hyllengren, Chief Financial Officer. We will begin with prepared remarks, then open the call for your questions. We would like to remind listeners that during the call, the company’s management will be making forward-looking statements.

NASDAQ.ATRA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
After losing 76% in the past year, Atara Biotherapeutics, Inc. (NASDAQ:ATRA) institutional owners...

Key Insights Institutions' substantial holdings in Atara Biotherapeutics implies that they have s...

Simply Wall St. via Yahoo Finance 31 Jan 2024

Seth Klarman's Firm Exits Atara Biotherapeutics Inc Holding

Overview of Seth Klarman (Trades, Portfolio)'s Recent Stock Transaction Warning! GuruFocus has de...

GuruFocus.com via Yahoo Finance 14 Jan 2024

Why AppLovin Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - AppLovin...

Now Read This: Disney, US Foods And 3 Stocks To Watch Heading Into Thursday

Benzinga 9 Nov 2023

Why Atara Biotherapeutics (ATRA) Shares Are Plummeting Today - Atara Biotherapeutics (NASDAQ:ATRA)

Atara Biotherapeutics, Inc. ATRA shares are trading lower after the company said that primary ana...

Benzinga 9 Nov 2023

US Stocks Mostly Flat; Jobless Claims Decline In Latest Week - Atara Biotherapeutics (NASDAQ:ATRA),...

U.S. stocks traded mostly flat this morning, following the release of jobless claims data. Follow...

Benzinga 9 Nov 2023

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.65%

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.65%

Investing.com 8 Nov 2023

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Q3 2023 Earnings Call Transcript

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Q3 2023 Earnings Call Transcript November 4, 2023 Opera...

Insider Monkey via Yahoo Finance 5 Nov 2023

Atara Biotherapeutics Inc (ATRA) Announces Q3 2023 Financial Results and Expanded Global Partnership

Atara Biotherapeutics Inc (NASDAQ:ATRA) announced its Q3 2023 financial results and an expanded g...

GuruFocus.com via Yahoo Finance 2 Nov 2023

Time To Worry? Analysts Just Downgraded Their Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Outlook

The latest analyst coverage could presage a bad day for Atara Biotherapeutics, Inc. (NASDAQ:ATRA)...

Simply Wall St. via Yahoo Finance 16 Jun 2023

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Analysts Are More Bearish Than They Used To Be

Today is shaping up negative for Atara Biotherapeutics, Inc. (NASDAQ:ATRA) shareholders, with the...

Simply Wall St. via Yahoo Finance 18 May 2023